Cubist Pharma (CBST) Tops Q3 EPS by 54c

Cubist Pharma (NASDAQ: CBST) reported Q3 EPS of $0.58, $0.54 better than the analyst estimate of $0.04. Revenue for the quarter came in at $309.2 million versus the consensus estimate of $305.5 million.

For earnings history and earnings-related data on Cubist Pharma (CBST) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Innovaro (INV) Misses Q2 EPS by 9c